Suzanne Redmon, APRN
Psychiatric/Mental Health · Asheville, NCNPI 1902346505
Payments from drug & device makers
Across 93 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$374
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$327
- Neurocrine Biosciences, Inc.$320
- AbbVie$250
- Otsuka America Pharmaceutical, Inc.$231
- Alkermes, Inc.$180
- plus $334 from 7 others
What the payments were for
- Food & beverage$1,86592%
- Education$1528%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $374 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $327 |
| Neurocrine Biosciences, Inc. | 14 | $320 |
| AbbVie | 12 | $250 |
| Otsuka America Pharmaceutical, Inc. | 14 | $231 |
| Alkermes, Inc. | 8 | $180 |
| Indivior Inc. | 4 | $86 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| AstraZeneca | 1 | $56 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Sunovion Pharmaceuticals Inc. | 2 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
How this compares
$2,016 in reported general payments places this provider in the 75th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 53 | $1,196 |
| Hydroxyzine Hcl | 16 | $1,179 |
| Prazosin Hcl | 27 | $968 |
| Gabapentin | 63 | $944 |
| Lurasidone Hcl | 22 | $808 |
| Olanzapine | 24 | $649 |
| Aripiprazole | 23 | $562 |
| Clonazepam | 30 | $503 |
| Trazodone Hcl | 41 | $341 |
| Lithium Carbonate ErLithium Carbonate | 13 | $322 |
| Lamotrigine | 22 | $262 |
| Fluoxetine Hcl | 13 | $216 |
| Buspirone Hcl | 12 | $203 |
| Lithium Carbonate | 13 | $185 |
| Duloxetine Hcl | 12 | $176 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Asheville
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
- Ajay PatelRaleigh$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.